In silico Docking Studies of Fingolimod and S1P1 Agonists
The sphingosine-1-phosphate receptor 1 (S1P1), originally the endothelial differentiation gene 1 receptor (EDG-1), is one of five G protein-coupled receptors (GPCRs) S1P1-5 that bind to and are activated by sphingosine-1-phosphate (S1P). The lipid S1P is an intermediate in sphingolipid homeostasis,...
Saved in:
Main Authors: | Alexander Marciniak (Author), Sara M. Camp (Author), Joe G. N. Garcia (Author), Robin Polt (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of generic fingolimod
by: O. M. Koval, et al.
Published: (2018) -
Drug Repurposing for Identification of S1P1 Agonists with Potential Application in Multiple Sclerosis Using In Silico Drug Design Approaches
by: Ali Akbar Alizadeh, et al.
Published: (2023) -
Toxicidad hepática por fingolimod
by: juan sebastian theran leon, et al.
Published: (2024) -
GLP-1 agonists in treatment of obesity
by: Władysław Orłowski, et al.
Published: (2023) -
Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release
by: David Encinas-Basurto, et al.
Published: (2022)